To address the myeloid cell-specific role of CYLD in inflammation-associated colon cancer, we induced colon carcinogenesis in CYLDΔ932mye mice by a single injection of the alkylating agent AOM followed by repeated cycles of inflammation induced by oral administration of DSS25 (Fig. 1a). This evidence concerns the gene CYLD and malignant colon neoplasm.